News
In its first-quarter 2025 investor letter, TimesSquare Capital U.S. Focus Growth Strategy highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products ...
Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. Cencora beat analysts’ revenue expectations by 5.2% last quarter, reporting ...
Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...
Cencora has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale ...
Cencora Inc (NYSE:COR), a prominent player in the Healthcare Providers & Services industry with a market capitalization of $45.7 billion, has been navigating a complex market landscape ...
Cencora, Inc. (COR), headquartered in Pennsylvania, is a global pharmaceutical sourcing and distribution leader offering innovative healthcare solutions and services. With a market cap of $45.2 ...
CONSHOHOCKEN, Pa. - Cencora, Inc. (NYSE: COR), a global pharmaceutical solutions organization with a market capitalization of $43.4 billion, has completed the acquisition of Retina Consultants of ...
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading ...
Forbes contributors publish independent expert analyses and insights. Global pharmaceutical company Cencora, Inc. recently announced the appointment of Pawan Verma as Executive Vice President and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results